Demonstrates enhanced accuracy and efficiency in organ-at-risk segmentation for head and neck radiotherapy, suggesting practical clinical applications.
Purpose: Accurate segmentation of head and neck organs-at-risk (OARs) remains a critical challenge in radiotherapy planning, where current single-modality approaches often fail to address the inherent complexity of soft tissue differentiation and interpatient anatomical variations.This study aims to develop a clinically robust autosegmentation framework that synergistically integrates multimodal imaging features while optimizing computational efficiency.Methods: We present M3-Net, a triple-interlocked deep learning architecture featuring:(1) Cross-modality fusion modules with attention-guided feature recalibration between CT density maps and MRI soft-tissue contrast; (2) A hierarchical multi-mask generator producing organ-specific, regional, and global masks through parallel encoding pathways; (3) A dual-task learning mechanism combining segmentation with deformable image registration to establish voxel-level modality correspondence.The model was trained on 200 retrospective cases (160/20/20 split) with expert-reviewed contours from a tertiary cancer center, supplemented by 10 prospective cases for clinical validation.Results: M3-Net demonstrated significant improvements across three key dimensions: Efficiency: Reduced inference time by 63.6% (54823s vs. 19815s, p<0.001) through dynamic mask prioritization.These strategies improved the performance of M3-Net.Sixty percent of the organs achieved a Dice similarity coefficient (DSC) greater than 0.88.M3-Net performed best in 93.3% of all organs.It achieved the best average surface distance (ASD) for all organs.For independent test cases, the speed and precision can meet clinical requirements.Conclusion: M3-Net establishes new state-of-the-art performance for head and neck OAR segmentation, by simultaneously addressing accuracy-efficiency tradeoffs and modality discordance.The clinically validated workflow reduces contouring time by 75% while maintaining dosimetrically significant precision, enabling rapid adoption in adaptive radiotherapy protocols.
No takes yet. Share an insight, caveat, or question.
Ni et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: